Milbank LLP advised DOT GmbH ("DOT") on the acquisition of all shares in Aristotech Industries GmbH ("Aristotech"). The parties have agreed to keep the financial details of the transaction confidential.
Aristotech, based in Luckenwalde near Berlin, operates one of the last independent forges for orthopedic implants in the European medical technology industry.
DOT is one of the world's leading providers of medical coating technologies for orthopedic implants. With the integration of Aristotech, DOT expands its service portfolio and positions itself as a comprehensive contract manufacturer for orthopedic implant manufacturers. Through this acquisition, DOT can now offer the entire manufacturing process from a single source, covering drop forging, precision machining (CNC), coating, and final packaging.
The Milbank team advising DOT on all legal aspects of the transaction was led by partner Martin Erhardt (Corporate/M&A, Munich). The team also included partner Thomas Kleinheisterkamp (Tax, Munich), special counsel Thomas Möller (Finance, Frankfurt), and associates Svenja Tauchmann (Corporate/M&A, Munich) and Robin Braun (Finance, Frankfurt).
